Robert Abouassaly,MD
@rabouassalymd
Urologic Oncologist, Robotics, Glickman Urological Institute
ID: 910941647927726080
https://my.clevelandclinic.org/staff/7099-robert-abouassaly 21-09-2017 18:59:48
78 Tweet
411 Followers
56 Following
Another award for another video🥇🥇. Ex vivo partial nephrectomy in a solitary kidney. Great job team Martin Hofmann Rebecca Campbell Yi-Chia Lin Cleveland Clinic Urology
MP52-02: Cystatin C is more sensitive than creatinine in detection of kidney dysfunction in non-weight-bearing individuals Join Stacy Jeong in S405 from 7:00 - 9:00 a.m. #AUA23
Congrats to the third and final winner of our #AUA23 #CleClinicCookieChallenge, Ayodeji Sotimehin! 🍪 DM us your email address to claim your prize. Thanks to everybody who participated, stopped by and ate a cookie!!
Raevti Bole, MD and Sarah C Vij MD study highlighted at #aua2023 plenary showing vasectomy volume expansion post-Dobbs Cleveland Clinic Urology
Monday morning plenary session - Sarah C Vij MD gives a fantastic concise summary for treatment options in young fertile men with hypogonadism. #aua2023 Cleveland Clinic Urology
Our terrific faculty Amer. Urol. Assn. #AUAInternAcademy Hands-on course by RoboUroMD & Ahmed Ghazi, joined by proctors Nazih Paul Khater, MD, FACS Evan Kovac Robert Abouassaly,MD JustinAhn David B Bayne Helena Chang Niels V Johnsen, MD MPH NickKavoussi Jessica E Kreshover MD Tracey L. Krupski Allie Tabakin, MD Carmen Tong
Fiore Roldán at UrusOncology Prostate Cancer Nomograms PreOp help in selection of candidates for lymphadenectomy, PostOp help predict oncological outcomes. PSMA-PET detects lesions with PSA as low as 0.2 Felipe Couñago PhD José Máximo Barros, MD 🇦🇷 Robert Abouassaly,MD Ronald Cadillo-Chavez #RaulMartos
Felipe Couñago PhD at UrusOncology Radiotherapy Vs RP similar oncological and functional outcomes at 2y Follow Up in low and intermediate risk prostate cancer José Máximo Barros, MD 🇦🇷 Fiore Roldán Robert Abouassaly,MD Ronald Cadillo-Chavez #RaulMartos
#RaulMartos at UrusOncology. BCG failure: Radical cistectomy is the current standard. Retrospective and Phase II trials showing promising results. We should consider clinical trials participation to BCG refractory patients. Felipe Couñago PhD José Máximo Barros, MD 🇦🇷 Robert Abouassaly,MD Fiore Roldán
Robert Abouassaly,MD at UrusOncology TURBT: Laser in lateral wall tumors (less obturator reflex). For dome, anterior wall and neck Monopolar/Bipolar energies are better than Laser (less residual tumor). BT enucleation may have some benefit Fiore Roldán Felipe Couñago PhD José Máximo Barros, MD 🇦🇷
José Máximo Barros, MD 🇦🇷 at UrusOncology Radiotherapy for primary RRC has showed long term efficacy in Phase II trials. Potential use for interruption of systemic therapy in mRCC Felipe Couñago PhD Fiore Roldán Robert Abouassaly,MD
Julio Pow-Sang at UrusOncology. Prostatic Biopsy TR Vs TP: Risk of infection marginally higher with TR, TP approach increases costs. Similar rate of positive biopsies with both approaches Fiore Roldán Felipe Couñago PhD Robert Abouassaly,MD José Máximo Barros, MD 🇦🇷
Excellent Uro-oncology meeting in the Dominican Republic organized by the Urus urology group. They were wonderful hosts, honored to have been invited. A great time with leaders in the field. Cleveland Clinic Urology José Máximo Barros, MD 🇦🇷 Fiore Roldán Ronald Cadillo-Chavez Dra. Merycarla Pichardo Felipe Couñago PhD
